As high-risk pharmaceutical products, these anticoagulants must strictly adhere to international pharmacopoeia standards such as USP (United States Pharmacopeia), BP (British Pharmacopeia), or EP (European Pharmacopoeia). Suppliers must possess a valid GMP (Good Manufacturing Practice) certificate. For cross-border trade, ensure the manufacturer provides a Certificate of Analysis (COA) for every batch and holds a CPP (Certificate of Pharmaceutical Product) to facilitate registration in the destination country.